11-oxo-2,3,5,6,7,11-Hexahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylic acid, 95.0%, 50mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate, 95.0%, 250mg

2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide>98.0%(HPLC)5g

E-plan EPLi S40x/0.65 infinity corrected IOS lens. Working distance 0.78 mm

ethyl 4-(2,4-dichlorophenyl)-3-oxobutanoate, 95.0%, 5g

fmoc-glu(otbu)-opfp, 97.0%, 25g

6-Aminobenzo[d]thiazol-2(3H)-one, 95.0%, 5g

2-oxo-2H-chromene-6-sulfonamide, 95.0%, 500mg

6-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine, 97%, 250mg

6-hydrazinyl-3,4-dihydropyrimidin-4-one, 95%, 25g

Blot incubation trays, MIDI, 5 Piece(s)

4,5-Dimethyl-2-nitrophenol, 97.0%, 1g

(S)-3,5-Difluoromandelic acid, 98%, 1g